Amplify Weight Loss Drug & Treatment ETF (THNR) — ()
Key Metrics
News
New Year, New Strategy: Navigating Weight Loss ETFs
Published: by:
Sentiment: Positive ()
With the start of 2026, the annual focus on weight loss resolutions presents a timely opportunity for financial advisors to discuss the investment potential of GLP-1 agonists with their clients. …
Read More
Weight Loss Drug ETF (THNR) Hits New 52-Week High
Published: by:
Sentiment: Positive ()
Amplify Weight Loss Drug & Treatment ETF THNR is probably on the radar for investors seeking momentum. The fund just hit a 52-week high and moved up 51.9% from its …
Read More
About Amplify Weight Loss Drug & Treatment ETF THNR
THNR provides access to global companies expected to economically benefit from weight loss drug development. THNR seeks investment results that generally correspond to the performance (before fees and expenses) of the VettaFi Weight Loss Drug & Treatment Index.